GBS
Woodstock, GA, United States
Woodstock, GA, United States

Time filter

Source Type

News Article | March 14, 2017
Site: www.techtimes.com

Life is unexpected and miracles occur when one least expects it. Captain Brandon Caldwell and his family's story is one which reinstates belief. Captain Caldwell, who came back after two months of deployment in Antarctica, never expected such a warm welcome — especially from his nine-month old boy Reagan who is visually impaired. Regan received his pair of blue glasses right after his dad was deployed to Antarctica, welcomed his military father with a smile of joy. The emotional moment was captured by his wife Amanda, who shared the video on her Facebook page. The video shows Regan sitting on his father's lap, who was still in his army uniform, singing "Patty Cake" to his son. With the new pair of blue glasses, Reagan watches his dad and listens to every word he utters. As the song continues, the boy is seen resting his head on his father's chest. Being so many months away from his nine-month old son, Caldwell thought Reagan may have forgotten him, which was certainly not the scene. "You can see how hard it was for Brandon to be away from Reagan by the emotion he showed when he finally had him in his arms again," shared Amanda to Cater News. Amanda who was a school teacher by profession, like most expectant mothers underwent testing and found she was positive with Group B Strep (GBS) in the 35 to 37 weeks. According to the American Pregnancy Association, one out of every pregnant woman is tested positive with GBS, so this was nothing to be worried about. However, after being tested with GBS, she was not informed anything about the severe consequences her child was going to suffer. The initial stage with baby Reagan was not an easy one for Amanda, as the child was detected with meningitis and sepsis 20 days after his birth. As a result of which, his family members took him to the Intensive Care Unit (ICU). The child also had to go through several seizures as a result of suffering from meningitis and sepsis. Based on his MRI results, the doctors suspected that the little baby may suffer from cerebral palsy or could be even mentally handicapped. However, Reagan is now showing positive improvements, and is also taking classes for speech therapy, visual impairment, as well as special education at home. His mother, Amanda left her job as a teacher to be with Reagan and also takes him to the doctor regularly, which also includes visits to the hospitals every six weeks. One can be a part of Reagan's journey by visiting Amanda's Facebook page, where she shares his updates, details about GBS, as well the medical challenges faced by the family. © 2017 Tech Times, All rights reserved. Do not reproduce without permission.


News Article | April 26, 2017
Site: www.prnewswire.com

Die Bewerber diese Jahr kämpfen um die begehrte Auszeichnung in einer von fünf Kategorien: Best Process Innovation, Best Shared Services Team, Excellence in Culture Creation, Excellence in Transformation und - die 2017 erstmals aufgeführte Kategorie - Excellence in Automation (unterstützt von Automation Anywhere). In diesen stark umkämpften Kategorien haben es Unternehmen wie Coca-Cola Hellenic, Tarmac, Sonae, Heathrow BSC und Shell in zwei Kategorien in die Shortlist geschafft. Zu weiteren nominierten Unternehmen gehören UPM, Siemens, Hexaware, Account NI, Vodafone, Maersk, Western Union, Société Générale, Wüstenrot & Württembergische, National Grid, Ericsson, WNS, Mas Legato, 3M und Lufthansa. Account NI, das Sieger-Unternehmen aus dem Vorjahr, wurde in der Kategorie Excellence in Transformation erneut in die Shortlist aufgenommen und hätte somit die Möglichkeit, den Award zum zweiten Mal in Folge zu gewinnen. Das Unternehmen muss sich mit Auftritten von Coca-Cola Hellenic, Hexaware, Shell and Sonae messen. Die Verleihung 2017 wird von Experten aus dem Bereich Shared Services beurteilt: Irina Chernousenko, Paul Bryanhill, Chris Gunning, George Connell, Ian Herbert, Mike Stops und Paul Theaker. Die Excellence Awards Ceremony wird anlässlich der alljährlichen Shared Services and Outsourcing Week - diese geht in die 17. Runde - abgehalten und zwar vom 15.-18. Mai 2017 - die Gewinner werden zu diesem Zeitpunkt bekanntgegeben. SSOW ist der erste europäische Shared Services-Event mit 580+ führenden Unternehmen aus den Bereichen Shared Services, GBS, Outsourcing and Transformation.


News Article | April 25, 2017
Site: www.sciencemag.org

Leah Durant was cleaning the unfinished basement of her home in Falls Church, Virginia, one day in October 2010 when she scraped her hand on a rusty nail. Not long after, the then-37-year-old lawyer was seated in her doctor's office, preparing to receive a tetanus vaccine—a preventive measure that since 1947 has reduced U.S. fatalities caused by the soil-borne bacterium Clostridium tetani 500-fold. Her physician stood to her left and leaned over her shoulder with the needle. The pain was immediate, and so excruciating that Durant screamed. "I knew right then and there that something had gone terribly wrong," she recalls. Six years later, driven by that painful jab, Durant has become a vaccine injury lawyer with a bustling practice in Washington, D.C., half a mile from a red brick building that houses what is popularly known as the vaccine court. Thirty years ago, federal law established that court—part of the U.S. Court of Federal Claims—to remove vaccine injury cases from the civil courts, where a wave of lawsuits had spooked vaccinemakers and was threatening to cause vaccine shortages. That law, the National Childhood Vaccine Injury Act of 1986, limited the legal liability of vaccinemakers and created the National Vaccine Injury Compensation Program (VICP) in the Department of Health and Human Services. The VICP is a no-fault route for people injured by vaccines to win damages from a government trust fund financed by an excise tax on vaccines. (Despite the law's title, adults, too, can win compensation for vaccine injuries.) Since its first case in 1988, the vaccine court has adjudicated more than 16,000 petitions and dismissed two-thirds of them. To the successful petitioners, and their lawyers, it has awarded about $3.6 billion. The system has attracted scores of attorneys, who are paid hourly legal fees of up to $430 regardless of whether a claim succeeds. The court's website lists 195 lawyers nationwide who are willing to take vaccine cases, although petitioners can hire others. Many are clearly in search of their piece of the $3.7 billion sitting in the trust fund today. A sampling of the bold proclamations on vaccine lawyers' websites include these: "WE HAVE RECOVERED MILLIONS FOR OUR CLIENTS"; "Pursue Compensation"; and "NO COST to you." Durant's website makes the same point, although in smaller fonts and classier prose. Yet she might be unique in that her own experience drove her into vaccine law. Once an immigration lawyer at the U.S. Department of Justice and later the outspoken director of a nonprofit advocating for stricter enforcement of immigration law, she changed her career course and ultimately became a full-time vaccine injury lawyer after that tetanus shot gone wrong. Durant's injury, her legal practice, and the petitions filed at the vaccine court offer a window into the real risks of vaccination. Those risks can be as severe as extremely rare, dramatic deaths from anaphylaxis—an overwhelming allergic reaction—or as quotidian as shoulder injuries like Durant's. And although petitions to the court do include the kind of bogus injuries that frighten parents, the most common, and prominent, of those has not been warmly received: Not once has the court compensated a petitioner claiming that a vaccine caused autism. Durant, who says she makes her living by winning compensation for genuine vaccine injuries, emphasizes the point. "Vaccines keep us healthy. They eradicate disease. If I had children, I would get them vaccinated." The vaccine court's data show that bona fide vaccine injuries are rare. For every million vaccine doses eligible for compensation that were distributed in the decade beginning in 2006, the court compensated one injury victim. Depending on the gravity of the disease in question, receiving a vaccine is orders of magnitude less dangerous than staying unvaccinated. The tetanus vaccine that Durant received causes a life-threatening allergic reaction in at most 0.0006% of people who get the shot. The U.S. case fatality rate from tetanus, by contrast, is 13.2%. "One injury from vaccines is one too many, but it is also important to keep perspective," says Sarah Atanasoff, a physician at the VICP in Rockville, Maryland. "The benefits of vaccination to the individual, the local community, and the nation as a whole far outweigh the risks." Petitions filed with the court suggest that among those real risks, shoulder injuries have become by far the most common. Rarer injuries include Guillain-Barré syndrome (GBS), a neurological malady associated with some influenza vaccines; anaphylaxis, a life-threatening allergic reaction that almost any vaccine can cause and occurs 1.3 times per million vaccinations; intussusception, an intestinal blockage that occurs in between one and five of every 100,000 infants vaccinated against rotavirus; and brachial neuritis (also called Parsonage-Turner syndrome), a painful inflammation of the nerves supplying the hand and arm, which afflicts up to 10 of every million tetanus vaccinees. Vaccination also can provoke (as well as prevent) febrile seizures, which occur in up to 5% of toddlers who become feverish for any reason. Those seizures are most common after measles, mumps, and rubella (MMR) or the combined MMR and chickenpox vaccine, occurring in up to 300 of each million children vaccinated. Typically lasting 1 to 2 minutes, the seizures can be frightening to witness. But they are transient and almost always without lasting effects. A cadre of medical experts at the VICP initially assesses injury claims, calling in lawyers from the Department of Justice to defend the government if they think the facts don't support a vaccine injury claim. Eight senior attorneys—called special masters and appointed by judges on the U.S. Court of Federal Claims—rule on the claims. The court is rarely asked to determine whether an injury has occurred—that is virtually always abundantly clear—but whether a vaccine caused that injury. Where the evidence shows that a vaccine did serious or fatal damage, as with a 4-year-old girl who died of anaphylaxis the day after receiving several childhood vaccines, the court awards substantial damages. Her parents received the maximum death benefit under the law: $250,000. But the court also draws lines when petitioners and their lawyers present weak, implausible cases—like that of a 4-month-old boy who was vaccinated and that night died, facedown, while sleeping under the same heavy covers as his mother. An autopsy found clear evidence that the baby had suffocated—and no evidence of vaccine-induced injury. The case was dismissed. And in 2010, the court declined to award compensation in an omnibus proceeding that grouped more than 5000 autism claims. Such petitions continue to fail. One typical, recent opinion reads: "The factual record simply does not support Petitioners' contention that the MMR vaccine had any connection to R.A.'s ASD [autism spectrum disorder] diagnosis." The stabbing pain in Durant's left shoulder worsened in the days after her tetanus shot. "I felt like my arm was falling off," she recalls. She couldn't carry her purse or hold a cup of coffee. She couldn't lift that arm above her head or place it on the steering wheel of her car. She contacted her doctor and relayed her fears that, whatever was going on, the vaccine had caused it. "That's not possible," she recalls him saying. "Needles aren't long enough to do that kind of damage." In fact, needles can do precisely that kind of damage if a vaccine is improperly administered too high on the upper arm, and the needle pierces the deltoid muscle and continues into the shoulder joint. There, physical damage from the needle and, more important, an immune reaction to the injected vaccine can provoke an inflammation that damages tendons, ligaments, and the fluid-filled sacs called bursas that reduce friction in the joint. Late in 2010, scientists in the government's VICP published a description of such injuries and gave them a name: shoulder injury related to vaccine administration. The government physicians, led by Atanasoff, had identified 13 adults who between 2006 and 2010 petitioned the court for compensation for shoulder injuries and submitted voluminous medical records. None had previous shoulder problems, but each had developed sudden, acute pain and a limited range of motion in a shoulder after a vaccination. Four patients needed surgery, and half of those needed a second operation. Their MRI reports showed shoulder joints riddled with inflammation. Half reported that the vaccine had been given "too high" in the shoulder. Most had received the vaccine in question—flu or tetanus, and in one case human papillomavirus—in the past, suggesting that the body's immune system was already primed to attack, in an immune response that led to serious, prolonged inflammation in the joint. The clinical results are not surprising to G. Russell Huffman, an orthopedic surgeon who specializes in shoulders at the University of Pennsylvania Perelman School of Medicine. "If you create this inflammatory response in the shoulder joint, it's going to be manifested not with an hour of pain but with days, months, or possibly years of pain." Shoulder injury petitions to the VICP have surged as annual flu vaccination has become routine—in 2010, the Centers for Disease Control and Prevention recommended it for everyone except the youngest babies. In 2012, the vaccine court published 15 decisions in which people alleged shoulder injuries. By 2016, 492 of its published decisions mentioned "shoulder injury." That trend may accelerate: Last month, the government added shoulder injuries to a list of injuries for which a victim does not have to prove causation. Now , petitioners need only document that they received a vaccine and within 48 hours developed acute, movement-limiting pain in that previously healthy shoulder. Durant went through 6 months of physical therapy followed by 18 months of at-home exercises before she felt fully recovered, she says. By then, she had begun to study vaccine injuries and case law. Gradually, she began to take on clients and build a full-time practice. If not for her injury, "I certainly wouldn't be doing this today," she says. Durant estimates that about 70% of her scores of clients past and present sustained shoulder injuries; the other 30% say they suffered from rare disorders such as brachial neuritis or GBS. Both diseases are thought to result from an autoimmune attack on the myelin that speeds conduction along the peripheral nerves. Both can therefore be triggered by a ramping up of the immune response—typically after an infection but also, on occasion, after a vaccine. Both can be seriously disabling. GBS can paralyze the legs, arms, and even the respiratory muscles. Brachial neuritis can leave arm and hand muscles weakened and wasted. That was the case for Mark Davis, an implant dentist in Clearwater, Florida. At age 70, he had no plans to retire. But one fall afternoon in 2013, his right hand began cramping so badly that he had to remove the dental tool he was holding by prying open his fingers with his left hand. Over the ensuing weeks, part of his hand grew numb and he lost the ability to retract his thumb—a crucial movement for operating syringes. He awoke one night with excruciating pain extending from his right shoulder to his hand. Remembering his anatomy from dental school, he mused that his pain and the growing weakness in his arm and hand tracked with the brachial plexus, a network of nerves that supplies the limb . Soon, he was forced to sell his practice at a loss. Weeks later, Davis happened to glance at a medical bill showing a routine tetanus injection he had received 2 weeks before his symptoms began. When he Googled "brachial plexus" and "tetanus vaccine," "my computer lights up like I've gone to the circus," he recalls. Davis had developed what Joseph Feinberg, a rehabilitation medicine specialist at the Hospital for Special Surgery in New York City, diagnosed several months later as brachial neuritis. Not long after that, again using the internet, Davis found Durant. The vaccine court is still processing his petition: The government contends that irritated nerves in his cervical spine—a problem common in dentists who spend a lifetime leaning over patients—may be responsible. Today, at 75, Davis's right bicep is withered. "My greatest loss is my inability to do what I really loved to do the most: work," he says. Still, he would get the tetanus shot again. "I am a very strong supporter of vaccination." Durant is still considering whether to petition the court for compensation for her own injury. "I am keeping my options open." On one thing she is not undecided: the importance of educating about vaccines. When parents contact her, asking how to get around a vaccination requirement for school entry, she doesn't offer help. Instead, she says, "I talk to them about my personal view about vaccinations and the fact that I feel vaccines are safe."


News Article | April 26, 2017
Site: www.prnewswire.com

The applicants this year are competing to win a coveted award in one of the 5 categories; Best Process Innovation, Best Shared Services Team, Excellence in Culture Creation, Excellence in Transformation, and the new for 2017 category, Excellence in Automation, sponsored by Automation Anywhere.  Across these highly competitive categories, Coca-Cola Hellenic, Tarmac, Sonae, Heathrow BSC and Shell have all made the shortlist in 2 categories, whilst other nominees include; UPM, Siemens, Hexaware, Account NI, Vodafone, Maersk, Western Union, Société Générale, Wüstenrot & Württembergische, National Grid, Ericsson, WNS, Mas Legato, 3M and Lufthansa. After winning in 2016, Account NI have found themselves on the shortlist for the Excellence in Transformation category once again, and could to win the award for a second year in a row. They are up against entries from Coca-Cola Hellenic, Hexaware, Shell and Sonae. The 2017 Awards are judged by experts in the Shared Services industry; Irina Chernousenko, Paul Bryanhill, Chris Gunning, George Connell, Ian Herbert, Mike Stops and Paul Theaker. The Excellence Awards Ceremony is hosted during the 17th Annual Shared Services & Outsourcing Week taking place on the 15th - 18th May 2017 where the winners will be announced. SSOW is the premier European Shared Services Event which hosts 580+ Shared Services, GBS, Outsourcing and Transformation leaders. For more information go to http://awards.ssoweek.com


News Article | April 26, 2017
Site: www.prnewswire.co.uk

The applicants this year are competing to win a coveted award in one of the 5 categories; Best Process Innovation, Best Shared Services Team, Excellence in Culture Creation, Excellence in Transformation, and the new for 2017 category, Excellence in Automation, sponsored by Automation Anywhere.  Across these highly competitive categories, Coca-Cola Hellenic, Tarmac, Sonae, Heathrow BSC and Shell have all made the shortlist in 2 categories, whilst other nominees include; UPM, Siemens, Hexaware, Account NI, Vodafone, Maersk, Western Union, Société Générale, Wüstenrot & Württembergische, National Grid, Ericsson, WNS, Mas Legato, 3M and Lufthansa. After winning in 2016, Account NI have found themselves on the shortlist for the Excellence in Transformation category once again, and could to win the award for a second year in a row. They are up against entries from Coca-Cola Hellenic, Hexaware, Shell and Sonae. The 2017 Awards are judged by experts in the Shared Services industry; Irina Chernousenko, Paul Bryanhill, Chris Gunning, George Connell, Ian Herbert, Mike Stops and Paul Theaker. The Excellence Awards Ceremony is hosted during the 17th Annual Shared Services & Outsourcing Week taking place on the 15th - 18th May 2017 where the winners will be announced. SSOW is the premier European Shared Services Event which hosts 580+ Shared Services, GBS, Outsourcing and Transformation leaders. For more information go to http://awards.ssoweek.com


News Article | April 21, 2017
Site: co.newswire.com

It's the idea of incremental growth—and just never giving up, being resilient, and always moving forward The morning of September 17, 2004, started like many other days for businessman and entrepreneur Barry Shore. At 55, Barry had just returned from a trip overseas with his 17-year old son. Barry is the Founder and CEO of Dlyte.com and is a successful serial entrepreneur across a variety of industries. Despite waking up physically strong, by the end of the day, Barry would be a quadriplegic, unable to move anything except his head—left to right. “I was standing up in the morning, and in the evening, I was in the hospital paralyzed from my neck down,” says Barry. Barry was later diagnosed with Guillain-Barré syndrome (GBS), a rare disorder in which the body's immune system attacks the nervous system. The disorder can be so devastating because it strikes without warning—and because there is no specific, singular cause known by doctors at this time. GBS affects about one person in 100,000, according to the National Institute of Neurological Disorders and Stroke. Barry would remain in various hospitals for 4 and a half months. He had a hospital bed in his own home for 2 years. He couldn’t turn over by himself, and he had braces on both legs—from his hips down to his ankles—for more than a year. But if you saw or heard Barry speak today, you’d be able to tell he’s full of life and just as vibrant and driven as before being diagnosed with GBS. Barry credits prayer, therapy, and love—PTL as he calls it—and conscious leadership as the factors that have turned his setback into a positive outcome.


News Article | May 8, 2017
Site: www.businesswire.com

NEW YORK--(BUSINESS WIRE)--First Data Corporation (NYSE: FDC), a global leader in commerce-enabling technology and solutions, today reported financial results for the first quarter ended March 31, 2017. Consolidated revenue for the first quarter was $2.8 billion, up 1% versus the prior year period, both as reported and excluding currency impacts. Total segment revenue was $1.7 billion for the quarter, up 2% versus the prior year period, or up 3% excluding the impacts from currency and the divestiture of the Australian ATM business that occurred at the end of the third quarter of 2016. For the first quarter 2017, net income attributable to First Data was $36 million (or $0.04 per diluted share), which compares to a net loss of $56 million in the prior year period. First quarter 2017 results include $56 million of debt extinguishment charges, while the prior year period included $46 million of debt extinguishment charges and $52 million of IPO-triggered stock-based compensation costs. Adjusted net income, which modifies net income for items such as debt extinguishment charges, stock-based compensation, amortization of acquisition intangibles, restructuring costs and other items, was $258 million (or $0.28 per diluted share), up $38 million or 17% compared to $220 million in the prior year period, driven by improved operating results and lower interest expense. Total segment earnings before interest, taxes, depreciation, and amortization (total segment EBITDA) in the first quarter 2017 was $651 million, up 2% versus the prior year period, or up 4% excluding impacts from currency and the Australian ATM divestiture. Total reported segment EBITDA margin improved 10 basis points to 37.7% in the quarter. “We delivered another quarter of solid earnings growth as our efforts to increase revenue, manage costs, and improve our capital structure are showing up in our bottom line,” said First Data Chairman and CEO Frank Bisignano. “We continue to make steady progress across key initiatives such as expanding our presence in the enterprise space, steadily improving the foundations of our SMB direct business in North America, and growing our international franchise. We reiterate our previously provided financial guidance for 2017 and over the medium term," Bisignano added. First quarter 2017 GBS segment revenue was $971 million, up 2% versus the prior year period, or up 3% excluding the impacts from currency and the Australian ATM divestiture. Within geographic regions, North America revenue of $751 million was up 2% versus the prior year period benefiting from 7% transaction growth. EMEA revenue was $127 million, down 9%, or down 3% excluding currency impacts, primarily driven by the non-recurrence of beneficial interchange rate changes in the prior year period, partially offset by transaction growth. Latin America revenue was $59 million, up 59%, or up 52% excluding currency impacts, driven by strong results in Brazil and Argentina. APAC revenue was $34 million, down 17%, or up 10% excluding impacts from currency and the Australian ATM divestiture, primarily driven by growth in India. First quarter 2017 GBS segment expenses were $589 million, up 2% versus the prior year period, or up 4% excluding the impacts from currency and the Australian ATM divestiture. First quarter 2017 GBS segment EBITDA was $382 million, up 2% versus the prior year period, or up 3% excluding impacts from currency and the Australian ATM divestiture. Segment EBITDA margin declined 10 basis points to 39.3% in the quarter. First quarter 2017 GFS segment revenue was $393 million, up 2% versus the prior year period, or up 5% excluding currency impacts. Within geographic regions, North America revenue of $236 million was up 1%, with growth in processing and print revenue partially offset by a decline in card personalization revenue. North America GFS card accounts on file grew 7% year over year. EMEA revenue was $101 million, down 2%, or up 9% excluding currency impacts, primarily driven by new business and internal growth primarily in the United Kingdom. Latin America revenue was $33 million, up 6%, or up 8% excluding currency impacts, driven by growth in Argentina and Colombia, partially offset by the non-recurrence of a previously disclosed license fee resolution in the prior year period. APAC revenue was $23 million, up 28%, or up 25% excluding currency impacts, primarily driven by growth in Australia. First quarter 2017 GFS segment expenses were $238 million, up 3% versus the prior year period, or up 6% excluding currency impacts. First quarter 2017 GFS segment EBITDA was $155 million, flat versus the prior year period, or up 3% excluding currency impacts. Segment EBITDA margin declined 80 basis points to 39.4% in the quarter. First quarter 2017 NSS segment revenue was $361 million, up 3% versus the prior year period. The Stored Value revenue grew mid-single digits, Security and Fraud revenue grew low single digits and EFT revenues were flat. First quarter 2017 NSS segment expenses were $205 million, up 2% versus the prior year period. First quarter 2017 NSS segment EBITDA was $156 million, up 3% versus the prior year period. Segment EBITDA margin improved 30 basis points to 43.2% in the quarter. In the first quarter 2017, cash flow from operations was $421 million, up 9% compared to $386 million in the prior year period. Free cash flow, which First Data defines as cash flow from operations, less capital expenditures and distributions to minority interests and other, was $261 million in the current quarter, up 24% compared to $211 million in the prior year period, primarily driven by improved operating results and working capital. Total borrowings at March 31, 2017 were increased to $18.6 billion, from $18.5 billion at December 31, 2016 driven by capital lease formation during the quarter. Net debt at March 31, 2017 declined $30 million to $18.1 billion, from $18.2 billion at December 31, 2016. As previously disclosed, in January 2017, the company closed on a new amortizing term loan totaling $1.3 billion with an interest rate of LIBOR plus 200 basis points and maturing in June 2020. The proceeds of these term loans and other funds were used to redeem all of the $1.4 billion 6.75% senior secured first lien notes due 2020, along with associated fees and expenses. In connection with this transaction, the company recorded approximately $56 million in loss on debt extinguishment. On April 26, 2017, First Data closed on a new term loan totaling $4.2 billion with an interest rate of LIBOR plus 250 basis points maturing in April, 2024. The proceeds of the term loan was used to redeem a $4.2 billion term loan with an interest rate of LIBOR plus 300 basis points maturing in March, 2021. To supplement the company's consolidated financial statements presented in accordance with generally accepted accounting principles, or GAAP, the company uses non-GAAP measures of certain financial performance. These non-GAAP measures include total segment revenue, total segment expense, total segment EBITDA, total segment EBITDA margin, adjusted net income, adjusted net income per diluted share, free cash flow and net debt. The company has included non-GAAP measures because management believes that they help to facilitate comparisons of the company's operating results between periods. The company believes the non-GAAP measures provide useful information to both management and users of our financial statements by excluding certain expenses, gains and losses that may not be indicative of its core operating results and business outlook. In disclosing year-over-year comparisons, the company has chosen to present non-GAAP measures because it believes that these measures provide users of our financial statements a consistent basis for reviewing the company's performance across different periods. These non-GAAP measures are not in accordance with, or an alternative to, measures prepared in accordance with GAAP and may be different from non-GAAP measures used by other companies. In addition, these non-GAAP measures are not based on any comprehensive set of accounting rules or principles. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the company's results of operations as determined in accordance with GAAP. These measures should only be used to evaluate the company's results of operations in conjunction with the corresponding GAAP measures. Reconciliation to the most directly comparable GAAP measure of all non-GAAP measures can be found in the tables included in this press release. The company excludes certain items and other adjustments from total segment revenue, total segment expense, total segment EBITDA, total segment EBITDA margin, adjusted net income and adjusted net income per diluted share. See reconciliations for a complete list of items excluded from non-GAAP measures. Adjusted net income is a non-GAAP financial measure used by management that provides additional insight on performance. Adjusted net income excludes amortization of acquisition-related intangibles, stock-based compensation, restructuring costs and other items affecting comparability and, therefore, provides a more complete understanding of continuing operating performance. Management believes that the presentation of adjusted net income provides users of our financial statements greater transparency into ongoing results of operations allowing them to better compare our results from period to period. The company uses free cash flow, a non-GAAP measure. Free cash flow is defined as cash flow used in/provided by operating activities less capital expenditures, distributions to minority interest, and other. The company considers free cash flow to be a liquidity measure that provides useful information to management and users of our financial statements about the amount of cash generated by the business which can then be used to, among other things, reduce debt outstanding. The company also uses net debt, a non-GAAP measure. Net debt is defined as total long-term borrowings plus short-term and current portion of long-term borrowings, at par value, excluding lines of credit used for settlement purposes, less cash and cash equivalents. The company believes that net debt provides additional insight on its level and management of leverage. Certain revenue measures in this release are presented excluding the estimated impact of foreign currency changes (constant currency). To present this information, monthly results in the current period for entities reporting in currencies other than United States dollars are translated into United States dollars at the average exchange rates in effect during the corresponding month of the prior fiscal year, rather than the actual average exchange rates in effect during the current fiscal year. Once translated, each month in the period is added together to calculate the constant currency current period results. The company believes that revenue growth is a key indication of how First Data is progressing from period to period and the non-GAAP constant currency financial measure is useful to investors, lenders and other creditors because such information enables them to measure the impact of currency fluctuations on the company's revenue from period to period. The company will host a conference call and webcast on Monday, May 8, 2017, at 8 a.m. ET to review the first quarter 2017 financial results. To listen to the call, dial +1 (844) 826-3033 (U.S.) or +1 (412) 317-5172 (outside the U.S.) at least 10 minutes prior to the start of the call. The call will also be webcast on the “Investor Relations” section of the First Data website at investor.firstdata.com along with a slide presentation to accompany the call. A replay of the call will be available through June 8, 2017, at +1 (877) 344-7529 (U.S.) or +1 (412) 317-0088 (outside the U.S.); passcode 10104877 and via webcast at investor.firstdata.com. Please note: Other than the replay, First Data has not authorized, and disclaims responsibility for any recording, replay or distribution of any transcription of this call. First Data Corporation (NYSE: FDC) is a global leader in commerce-enabling technology and solutions, serving approximately six million business locations and 4,000 financial institutions in more than 100 countries around the world. The company’s 24,000 owner-associates are dedicated to helping companies, from start-ups to the world’s largest corporations, conduct commerce every day by securing and processing more than 2,800 transactions per second and $2.2 trillion per year. Notice to Investors, Prospective Investors and the Investment Community; Cautionary Information Regarding Forward-Looking Statements Certain matters we discuss in our public statements may constitute forward-looking statements. You can identify forward-looking statements because they contain words such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “intends,” “plans,” “estimates,” or “anticipates” or similar expressions which concern our strategy, plans, projections or intentions. Examples of forward-looking statements include, but are not limited to, all statements we make relating to revenue, earnings before net interest expense, income taxes, depreciation, and amortization (EBITDA), earnings, margins, growth rates, and other financial results for future periods. By their nature, forward-looking statements speak only as of the date they are made; are not statements of historical fact or guarantees of future performance; and are subject to risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify. Actual results could differ materially and adversely from our forward-looking statements due to a variety of factors, including the following: (1) adverse impacts from global economic, political, and other conditions affecting trends in consumer, business, and government spending; (2) our ability to anticipate and respond to changing industry trends, including technological changes and increasing competition; (3) our ability to successfully renew existing client contracts on favorable terms and obtain new clients; (4) our ability to prevent a material breach of security of any of our systems; (5) our ability to implement and improve processing systems to provide new products, improve functionality, and increase efficiencies; (6) the successful management of our merchant alliance program which involves several alliances not under our sole control and each of which acts independently of the others; (7) our successful management of credit and fraud risks in our business units and merchant alliances, particularly in the context of eCommerce and mobile markets; (8) consolidation among financial institution clients or other client groups that impacts our client relationships; (9) our ability to use our net operating losses without restriction to offset income for US tax purposes; (10) our ability to improve our profitability and maintain flexibility in our capital resources through the implementation of cost savings initiatives; (11) the acquisition or disposition of material business or assets; (12) our high degree of leverage; (13) adverse impacts from currency exchange rates or currency controls imposed by any government or otherwise; (14) changes in the interest rate environment that increase interest on our borrowings or the interest rate at which we can refinance our borrowings; (15) the impact of new or changes in current laws, regulations, credit card association rules, or other industry standards; and (16) new lawsuits, investigations, or proceedings, or changes to our potential exposure in connection with pending lawsuits, investigations or proceedings, and various other factors set forth in our Annual Report on Form 10-K for the period ended December 31, 2016, including but not limited to, Item 1 - Business, Item 1A - Risk Factors, and Item 7 - Management’s Discussion and Analysis of Financial Condition and Results of Operations. Except as required by law, we do not intend to revise or update any forward-looking statement as a result of new information, future developments or otherwise.


Itransition Included on the 2017 Global Outsourcing 100 List with Maximum Scores in Three Areas Itransition is included in the Global Outsourcing 100 List for 9 successive years; achieves special recognition in 5 areas and maximum scores in 3 areas. The 2017 Global Outsourcing 100 recognizes the world’s best outsourcing service providers. These list is based on applications received, and judging is based on a rigorous scoring methodology that includes reviews by an independent panel of IAOP customer members with extensive experience in selecting outsourcing service providers and advisors for their organizations. The 2017 panel is led by IAOP CEO Debi Hamill and Chairman Michael F. Corbett. The panel includes: · Daniel Beimborn, Professor, Frankfurt School of Finance & Management · Teresa Harris, COP, Global Supplier Relationship Manager, GE · Mary D. Lewis, Sourcing Manager II, Supply Chain Management, Sprint · Cheryl Seely, COP, Manager, Thomson Reuters · Paul Quaglia, COP, CIO, Scientific Games · Scott Singer, Managing Director, GBS, Rio Tinto As before, Size and Growth, Awards and Certifications, Programs for Innovation and Corporate Social Responsibility, as well as Customer References were the scored areas influencing the overall company score awarded by IAOP. To achieve “stars” in these categories, a company had to score 5 or more points (on a scale of 0-8). According to the 2017 GO100 results, Itransition not only scored above the industry average, but also beat its own overall score from 2016. Itransition stood out from competitors by being named Top Company in the areas of Customer References, Awards & Certifications, and Programs for Innovation, for which it received 8 points, the absolute maximum number. In the Programs for Innovation area, Itransition reached 8 as well beating its 2016 score by 3 points. The company also upped its 2016 score in the Company Awards area by 4 points. Having been included on the GO100 list for the last 9 consecutive years, Itransition received an additional distinction of Super Star of the Global Outsourcing 100 for demonstrating sustained excellence. “Buyers understand there are hundreds of qualified service providers and advisors out there, but what they really need to understand now is what makes each one exceptional,” said IAOP CEO, Debi Hamill. “The Global Outsourcing 100 and World’s Best Advisors lists have done just that. We are proud to recognize Itransition for being among the highest rated companies in Customer References, Company Awards, Company Certification, and Programs for Innovation.” “Since 2011, Itransition has enabled my organization to deliver quality products against tight deadlines. In late 2015, my organization needed to create two native, digital-government mobile applications. Itransition helped us through everything: requirements analysis, software design and engineering, automated building and testing, and tech writing. I personally recommended that Itransition be included in the 2017 Global Outsourcing list, and I am very happy to know they were selected,” commented Martin Duclos, Deputy Executive Director at NSPARC. “I strongly recommend Itransition to any business looking to outsource assistance for large-scale software development and testing,” he added. “We are honored to be included on the 2017 Global Outsourcing 100® list once again, delighted to surpass our previous results. Last year was a year of pushing the boundaries for the company, and those dynamics are reflected in higher scores from IAOP,” said Alex Demichev, Itransition’s CEO. “Achieving maximum scores in Customer References, Certification and Programs for Innovation areas is the result of our dedication to our clients, investment in constant specialist training and passion for innovation. Recognition from the globally acclaimed judges recharges our drive to deliver the best outsourcing services on the market.” About IAOP IAOP is the go-to association leading the way to improve outsourcing outcomes by bringing together customers, providers and advisors in a collaborative, knowledge-based environment that promotes professional development, recognition, certification and excellence. With over 120,000 members and affiliates worldwide, IAOP is not only on top of the latest trends but in front of them. Through its expansive global chapter network, premier training and certification programs, knowledge center, member community and more, IAOP helps members learn, grow and succeed. For more information and how you can become involved, visit www.IAOP.org About Itransition Founded in 1998, Itransition is a rapidly growing global provider of application and software product development services headquartered in the USA. The company delivers high quality services to customers from startups & SMBs to Fortune 500 companies through its 1,500 strong development center in Eastern Europe, offering a well-balanced blend of technology skills, domain knowledge, effective methodology, and passion for IT. Itransition is continuously recognized as a leader in outsourced software development by independent research agencies. For details, please visit: www.itransition.com Denver, CO, April 17, 2017 --( PR.com )-- Itransition , an outsourced software development vendor providing full-cycle IT services, is once again named one of the top service delivery providers in the global outsourcing industry by IAOP®, with special distinction and maximum scores in three areas: Customer References, Awards & Certifications, and Programs for Innovation.The 2017 Global Outsourcing 100 recognizes the world’s best outsourcing service providers. These list is based on applications received, and judging is based on a rigorous scoring methodology that includes reviews by an independent panel of IAOP customer members with extensive experience in selecting outsourcing service providers and advisors for their organizations.The 2017 panel is led by IAOP CEO Debi Hamill and Chairman Michael F. Corbett. The panel includes:· Daniel Beimborn, Professor, Frankfurt School of Finance & Management· Teresa Harris, COP, Global Supplier Relationship Manager, GE· Mary D. Lewis, Sourcing Manager II, Supply Chain Management, Sprint· Cheryl Seely, COP, Manager, Thomson Reuters· Paul Quaglia, COP, CIO, Scientific Games· Scott Singer, Managing Director, GBS, Rio TintoAs before, Size and Growth, Awards and Certifications, Programs for Innovation and Corporate Social Responsibility, as well as Customer References were the scored areas influencing the overall company score awarded by IAOP. To achieve “stars” in these categories, a company had to score 5 or more points (on a scale of 0-8).According to the 2017 GO100 results, Itransition not only scored above the industry average, but also beat its own overall score from 2016. Itransition stood out from competitors by being named Top Company in the areas of Customer References, Awards & Certifications, and Programs for Innovation, for which it received 8 points, the absolute maximum number. In the Programs for Innovation area, Itransition reached 8 as well beating its 2016 score by 3 points.The company also upped its 2016 score in the Company Awards area by 4 points. Having been included on the GO100 list for the last 9 consecutive years, Itransition received an additional distinction of Super Star of the Global Outsourcing 100 for demonstrating sustained excellence.“Buyers understand there are hundreds of qualified service providers and advisors out there, but what they really need to understand now is what makes each one exceptional,” said IAOP CEO, Debi Hamill. “The Global Outsourcing 100 and World’s Best Advisors lists have done just that. We are proud to recognize Itransition for being among the highest rated companies in Customer References, Company Awards, Company Certification, and Programs for Innovation.”“Since 2011, Itransition has enabled my organization to deliver quality products against tight deadlines. In late 2015, my organization needed to create two native, digital-government mobile applications. Itransition helped us through everything: requirements analysis, software design and engineering, automated building and testing, and tech writing. I personally recommended that Itransition be included in the 2017 Global Outsourcing list, and I am very happy to know they were selected,” commented Martin Duclos, Deputy Executive Director at NSPARC. “I strongly recommend Itransition to any business looking to outsource assistance for large-scale software development and testing,” he added.“We are honored to be included on the 2017 Global Outsourcing 100® list once again, delighted to surpass our previous results. Last year was a year of pushing the boundaries for the company, and those dynamics are reflected in higher scores from IAOP,” said Alex Demichev, Itransition’s CEO. “Achieving maximum scores in Customer References, Certification and Programs for Innovation areas is the result of our dedication to our clients, investment in constant specialist training and passion for innovation. Recognition from the globally acclaimed judges recharges our drive to deliver the best outsourcing services on the market.”About IAOPIAOP is the go-to association leading the way to improve outsourcing outcomes by bringing together customers, providers and advisors in a collaborative, knowledge-based environment that promotes professional development, recognition, certification and excellence. With over 120,000 members and affiliates worldwide, IAOP is not only on top of the latest trends but in front of them. Through its expansive global chapter network, premier training and certification programs, knowledge center, member community and more, IAOP helps members learn, grow and succeed. For more information and how you can become involved, visit www.IAOP.orgAbout ItransitionFounded in 1998, Itransition is a rapidly growing global provider of application and software product development services headquartered in the USA. The company delivers high quality services to customers from startups & SMBs to Fortune 500 companies through its 1,500 strong development center in Eastern Europe, offering a well-balanced blend of technology skills, domain knowledge, effective methodology, and passion for IT. Itransition is continuously recognized as a leader in outsourced software development by independent research agencies. For details, please visit: www.itransition.com Click here to view the company profile of Itransition Click here to view the list of recent Press Releases from Itransition


News Article | February 15, 2017
Site: globenewswire.com

15 February 2017 - Solid results through predictable project execution. Kvaerner delivered an adjusted EBITDA of NOK 219 million in the fourth quarter, and NOK 680 million for 2016. "Predictable project execution coupled with cost reductions and productivity improvements continue to be the key drivers behind our strong performance," says Kvaerner's President & CEO Jan Arve Haugan. Kvaerner delivered solid operational performance in fourth quarter, driven by successful execution and completion of milestones in the projects. The effect of better performance and improved project-portfolio mix has resulted in a higher margin compared to last year. In the fourth quarter 2016, total revenues, including jointly controlled entities (Field Development segment), amounted to NOK 2 378 million, compared to NOK 3 334 million in the fourth quarter last year. Adjusted EBITDA, including jointly controlled entities, ended at NOK 232 million (9.7 percent EBITDA margin), up from NOK 202 million (6.1 percent EBITDA margin) in the corresponding quarter in 2015. Net cash inflow from operating activities was NOK 244 million in fourth quarter. "During one and the same week in December, we flawlessly executed three very well planned, major operations. Common for all three - Hebron GBS, Njord A and the Johan Sverdrup riser platform jacket - was extremely high precision and safe execution. Delivery of such important parts of the complex projects predictably is the best possible marketing for new contracts," says Jan Arve Haugan. Order intake in the fourth quarter was NOK 768 million. Per 31 December 2016, Kvaerner's order backlog, including Kvaerner's scope of work of jointly controlled entities, was NOK 6 459 million, down from NOK 8 397 million at the end of the third quarter. "From 2014 to 2016, we improved our cost base for new projects with about 15 to 20 percent. From 2016 and into 2017, we continue the improvements. Our ambition is that we for new topside bids in 2017 have a cost base which is 20 to 25 percent lower than what we had three years ago. We see some important upcoming prospects in the market. The reduced cost base combined with a predictable delivery model will enhance our competitive position and should be seen as a strong enabler to increase our order book," says Jan Arve Haugan. Subsequent to the quarter, Kvaerner has been awarded a NOK 450 million contract for offshore hook-up of the Johan Sverdrup riser platform, plus a NOK 200 million decommissioning contract. Full year 2016 results Total operating revenues, including jointly controlled entities, were NOK 10 364 for the full year 2016, compared with NOK 14 917 in 2015. EBITDA, including jointly controlled entities, ended at NOK 741 million for the full year 2016 (EBITDA margin 7.1 percent), up from NOK 613 million for the full year 2015 (EBITDA margin: 4.1 percent). At the end of the year, Kvaerner's credit facilities were undrawn and net cash was NOK 3 billion. The Board of Directors has proposed no dividend distribution for second half of 2016. A robust balance sheet and cash position is important to maintain resilience through the challenging cycle and it should support the ambition to come out of the period with an even stronger business. The solid financial position is a competitive lever when positioning for new contracts. It also provides flexibility to pursue selected opportunities for strategic development. The full report and presentation can be downloaded from www.kvaerner.com and the links below. For further information, please contact: About Kvaerner: Kvaerner is a leading provider of engineering, procurement and construction (EPC) services, and delivers offshore installations and onshore plants for upstream oil and gas production around the world. Kvaerner ASA, through its subsidiaries and affiliates ("Kvaerner"), is an international contractor and preferred partner for oil and gas operators and other engineering and fabrication contractors. Kvaerner and its approximately 2 700 HSSE-focused and experienced employees are recognised for delivering some of the world's most amazing and demanding projects. In 2016, the Kvaerner group had consolidated annual revenues of close to NOK 8 billion and the company reported an order backlog at 31 December 2016 of NOK 6.5 billion. Kvaerner is publicly listed with the ticker "KVAER" at the Oslo Stock Exchange. For further information, please visit www.kvaerner.com. To subscribe or unsubscribe to our press releases, please see our web page: http://www.kvaerner.com/en/toolsmenu/Media/Subscribe-to-releases/ This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.


Grant
Agency: European Commission | Branch: FP7 | Program: CSA-SA | Phase: FP7-PEOPLE-2011-NIGHT | Award Amount: 124.70K | Year: 2011

Light11 is conceived as an event driving a cultural change about researchers for the benefit of research-end users. Light11 will take place in Rome, the capital of the country, and in 4 additional locations in the South of Italy thus covering large part of the country. Light11 makes scientists from all over Italy converge to Rome, Benevento, Cosenza, Palermo and Bari. Light11 will last from 5.p.m. on 23 September to 1.a.m on 24 September. Light is celebrating its 4th year of life. As in previous editions, we dedicate the RN to a specific theme. This year Light11 is dedicated to: Real science and TV fictions in order to show that real scientists may be as interesting and attracting as those proposed by TV fictions and that science is continuously shaping our daily existence in order to improve the understanding of the world around us and to stimulate curiosity for further developments. We will use the protagonists of science-related TV shows as a springboard for dialogue with the public in order to improve the image of scientists In order to ignite peoples curiosity towards scientists work, Light11 will set-up a number of actions/events during the whole RN. The actions will be run in continuation in all the locations allowing visitors to freely pass from one area to the other without waiting for something to happen. The activities will be organised around 5 main areas: o Hands-on workshops with live demonstrations and hands-on experiments; o Big ideas from young minds area, where potential tomorrows scientists will present their special achievements; o Globe Science Theatre where groups of artists/sportsmen that have at least one member of the performing team actively engaged with scientific research will be on stage during the whole RN; o Outside activities on sports and music o European Corner with Marie Curie research and training networks teams witnessing and answering public demands;

Loading GBS collaborators
Loading GBS collaborators